The SCOUT project, launched by CPI to help Scottish SMEs overcome challenges of innovation, are hosting a free webinar on February 9th 2022, centred on ‘Powerful Partnering’.
Exactmer’s CEO, Andrew Livingston will outline the company’s journey and the successful partnership that supported its development. He will then be joined by representatives from the new Medicines Manufacturing Innovation Centre (MMIC) project, aimed at collaboratively revolutionising the manufacture of oligonucleotides. The panel has now been finalised, and includes Astra Zeneca’s Terry Reed, and Barrie Cassey from CPI.
Last year, Exactmer became a central part of a new project, launched in the MMIC that aims to revolutionise the manufacture of oligonucleotides. The collaboration, which includes AstraZeneca and Novartis, enables the partners to utilise their combined expertise across scale-up, analytics, and process development, ultimately transforming the oligonucleotide supply chain. The MMIC employs a ‘Grand Challenge’ model, consisting of collaborative projects that bring together effective partnerships to address key issues raised by pharmaceutical industry consortia.
This webinar will explore the opportunities and challenges encountered in developing successful partnerships, with the stakeholders sharing insights and experiences to help accelerate innovation process.
To find out more and register, click here.